Ropinirole
Top View
- WO 2014/006004 Al 9 January 2014 (09.01.2014) P O P C T
- Ropinirole and Pramipexole, the New Agonists
- Drug Repurposing Is a New Opportunity for Developing Drugs Against Neuropsychiatric Disorders
- Impulse Control Disorders in Patients with Hyperpolactinemia Treated With
- New Evidence for Reduced Leg Oxygen Levels in Restless Legs Syndrome Erik K
- Clinical Characteristics of Pramipexole-Induced Peripheral Edema
- Overview of Parkinson's Disease Treatment Options
- REQUIP® (Ropinirole Hydrochloride) Tablets
- Neupro, INN-Rotigotine
- Ropinirole for Restless Legs Syndrome
- Medicines-Management-December-2016-Newsletter
- Bordeaux JJF Pharmacological Treatment of Parkinson's Disease
- Behavioral Tests in Neurotoxin-Induced Animal Models of Parkinson’S Disease
- Therapeutic Class Overview Dopamine Agonists
- Interactions with Entry & Integrase Inhibitors
- Potential Herb-Drug Interactions Chart
- Update: Treatments for Motor Symptoms of Parkinson's Disease
- EMIT Drugs-Of-Abuse Urine Assays Cross-Reactivity List